Most studies have shown that the critical target of platinum resistance related to glutamine metabolism is GLS; knock out of GLS can resensitize platinum-resistant ovarian cancer cells to cisplatin, and overexpression of GLS can lead to platinum resistance (69). Here, GLS is linked to ovarian carcinoma.